Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- HONEY G. E., TRUELOVE S. C. Prognostic factors in myocardial infarction. Lancet. 1957 Jun 15;272(6981):1209–1212. doi: 10.1016/s0140-6736(57)91787-7. [DOI] [PubMed] [Google Scholar]
- JOHNSON R., DAVID A., CHARTIER Y. Clinical experience with G-23350 (sintrom). Can Med Assoc J. 1957 Oct 15;77(8):756–761. [PMC free article] [PubMed] [Google Scholar]
- LONG L. A., COLPRON G., MARION P. A new 4-oxycoumarin derivative, G-23350 (sintrom). Can Med Assoc J. 1956 Aug 15;75(4):261–268. [PMC free article] [PubMed] [Google Scholar]
- MOESCHLIN S., SCHORNO H. Klinische Erfahrungen mit einem neuen 3-Oxycumarin-Derivat: Sintrom (Geigy 23350). Schweiz Med Wochenschr. 1955 Jun 11;85(24):590–592. [PubMed] [Google Scholar]
- MONTIGEL C., PULVER R. Tierexperimentelle Untersuchungen über ein neues hochaktives 4-Oxycumarin-Derivat mit kurzer Wirkung: Sintrom (G 23350). Schweiz Med Wochenschr. 1955 Jun 11;85(24):586–590. [PubMed] [Google Scholar]
- NEILL E. C., MOON R. Y., VANDER VEER J. B. Clinical evaluation of a new oral anticoagulant sintrom. Circulation. 1957 May;15(5):713–720. doi: 10.1161/01.cir.15.5.713. [DOI] [PubMed] [Google Scholar]
- PRATT G. Clinical experience with a new antithrombotic substance. N Y State J Med. 1956 Jun 15;56(12):1945–1947. [PubMed] [Google Scholar]